Covista (CVSA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
2 Oct, 2026Executive summary
Annual meeting scheduled virtually for November 11, 2026, at 9:30 a.m. Central; voting closes November 10 at 11:59 p.m. ET, or November 9 for plan shares.
Agenda includes director elections, auditor ratification, an advisory say-on-pay vote, and approval of the 2026 Equity Incentive Plan.
Voting matters and shareholder proposals
Board recommends For all proposals: 11 director nominees, auditor ratification, say-on-pay, and the 2026 Equity Incentive Plan.
Other business may be considered at the meeting or any adjournment.
Board of directors and corporate governance
Director nominees: Stephen W. Beard, William W. Burke, Emily C. Chiu, Donna J. Hrinak, Georgette Kiser, Liam Krehbiel, Michael W. Malafronte, Sharon L. O'Keefe, Kenneth J. Phelan, Leslie Storms, and Betty Vandenbosch; Board recommends For each.
Latest events from Covista
- Voting clarification: broker non-votes affect quorum and auditor ratification only.CVSA
Proxy filing - FY26 outperformance closes one strategy; a new plan targets growth through FY29.CVSA
Proxy filing - Sustained growth, campus expansion, and strategic partnerships drive a leading healthcare education platform.CVSA
2026 Jefferies Healthcare Services and Technology Conference - Double-digit EPS growth, record enrollments, and strong FY27 outlook delivered.CVSA
Q4 2026 - Record enrollment and revenue growth, raised guidance, and strong capital allocation.CVSA
Q3 2026 - AI-driven growth and operational excellence support double-digit earnings and enrollment targets.CVSA
Investor Day 2026 - Enrollment and revenue growth drive strong earnings and positive 2026 outlook.CVSA
Q1 2026 - Double-digit enrollment and revenue growth drive record results and strong FY25 outlook.CVSA
Q4 2024 - Record enrollment and margin gains highlight strong growth in healthcare education.CVSA
Baird 2024 Global Consumer, Technology & Services Conference